Cannabis, Sleep Architecture & Insomnia: Clinical Evidence | CĒD Clinic
Cannabis, Sleep Architecture & Insomnia: Clinical Evidence & Titration
Dr. Benjamin Caplan examines the pharmacology of cannabinoid sleep therapy, exploring CBN vs. CBD mechanisms, slow-wave sleep enhancement, and tapering sedative medications.
💤 REM vs. Slow-Wave Deep Sleep
While high-dose recreational cannabis suppresses rapid eye movement (REM) dreaming, clinically titrated low-dose cannabinoid therapy prolongs Stage 3/4 slow-wave restorative sleep, promoting tissue repair and cognitive clearance.
🧬 Cannabinol (CBN) & Sedative Synergy
As THC oxidizes into CBN, its affinity for CB2 receptors increases. When formulated with sedating terpenes like myrcene and linalool, CBN creates a synergistic entourage effect calming nocturnal autonomic hyperarousal.
🛑 De-Prescribing Sleep Aid Risks
Sedatives such as benzodiazepines and z-drugs (e.g. zolpidem) carry steep fall risks, tolerance build-up, and motor impairment in older adults. Clinician-monitored cannabinoid protocols offer a viable tapering off-ramp.
60-Second Sleep Lessons & Nocturnal Rest Reels
Rapid clinical breakdowns from Dr. Benjamin Caplan on sleep kinetics, CBN formulations, and circadian resetting.
